Search

everythinglearnresearchcommunity

for

Search:↓

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

FDG PET/CT scans can change cancer treatment plans for dogs.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.